Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 1.00 |
| ▸ | CA2 | P00918 | 7/20 | 1.00 |
| ▸ | CA9 | Q16790 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.81 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CTRC | Q99895 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29707656 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL14353888 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL14353945 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL15456115 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL1300527 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL24435598 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL14353889 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL1300528 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL14353944 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL13784681 | 1.00 | CA12 (1.00) | CA12CA2CA9KDM4ECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7161046-B2 | Process for the preparation of alkylene glycols | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2007-01-09 | — | — | US | claimed |
| US-8123976-B2 | Alkaline aqueous solution composition used for washing or etching substrates | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20090001315-A1 | ALKALINE AQUEOUS SOLUTION COMPOSITION USED FOR WASHING OR ETCHING SUBSTRATES | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2009-01-01 | — | — | US | disclosed |
| US-7253325-B2 | Process for the preparation of alkylene glycols | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2007-08-07 | — | — | US | disclosed |
| US-20070066856-A1 | Process for the preparation of alkylene glycols | SAUDI BASIC INDUSTRIES CORPORATION | 2007-03-22 | — | — | US | disclosed |
| US-7161046-B2 | Process for the preparation of alkylene glycols | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2007-01-09 | — | — | US | disclosed |
| US-6328943-B1 | CONTACTING IRON SULFIDES AND/OR PRECURSORS THEREOF IN THE PRESENCE OF AIR WITH AN EFFECTIVE INHIBITING AMOUNT OF A TREATMENT COMPOUND SELECTED FROM AMINE, ALCOHOL, KETONE, OR MIXTURES | BETZDEARBORN INC. | 2001-12-11 | — | — | US | disclosed |
| US-6127301-A | Catalyst system and method for reaction of olefin | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066856-A1 | Process for the preparation of alkylene glycols | PCNA, IDH1, POLN | CA12 425/4885CA2 1693/4885CA9 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.